US OptionsDetailed Quotes
AMED250117P75000
- 0.05
- 0.000.00%
15min DelayClose Jan 10 16:00 ET
0.05High0.05Low
0.05Open0.05Pre Close6 Volume3.23K Open Interest75.00Strike Price30.00Turnover74.53%IV18.44%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier6DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type-0.0153Delta0.0044Gamma1838.00Leverage Ratio-0.0238Theta-0.0002Rho-28.21Eff Leverage0.0046Vega
Amedisys Stock Discussion
Sign in to post a comment
$Amedisys (AMED.US)$ divergency with good fundamental Also gap so it looks good and risk to rewards is acceptable
1
$Inhibikase Therapeutics (IKT.US)$
learn from
$Amedisys (AMED.US)$
$AMC Entertainment (AMC.US)$
$Fulcrum Therapeutics (FULC.US)$
JonesTrading analyst Soumit Roy initiates coverage on Inhibikase Therapeutics (NASDAQ:IKT) with a Buy rating and announces Price Target of $12.
$PharmaCyte Biotech (PMCB.US)$
learn from
$Amedisys (AMED.US)$
$AMC Entertainment (AMC.US)$
$Fulcrum Therapeutics (FULC.US)$
JonesTrading analyst Soumit Roy initiates coverage on Inhibikase Therapeutics (NASDAQ:IKT) with a Buy rating and announces Price Target of $12.
$PharmaCyte Biotech (PMCB.US)$
2
No comment yet
Kofi : Do u see it going above 100 ?